Relationship between serum cholesterol and Graves' orbitopathy (GO): a confirmatory study

scientific article published on 19 June 2018

Relationship between serum cholesterol and Graves' orbitopathy (GO): a confirmatory study is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S40618-018-0915-Z
P698PubMed publication ID29923059

P2093author name stringE Sabini
C Marcocci
M Leo
F Menconi
M Marinò
P Vitti
M Nardi
R Rocchi
B Mazzi
A Sframeli
G Lanzolla
M A Profilo
P2860cites workThe evaluation and treatment of graves ophthalmopathyQ26862144
A century of cholesterol and coronaries: from plaques to genes to statinsQ28080618
Diet induced mild hypercholesterolemia in pigs: local and systemic inflammation, effects on vascular injury - rescue by high-dose statin treatmentQ28535160
Physiology and pathophysiology of liver lipid metabolism.Q35662655
Risk factors for developing thyroid-associated ophthalmopathy among individuals with Graves disease.Q35830997
The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' OrbitopathyQ36811289
Smoking and thyroidQ38098569
Prevalence and natural history of Graves' orbitopathy in the XXI centuryQ38099144
Role of genetic and non-genetic factors in the etiology of Graves' disease.Q38271025
Total thyroid ablation in Graves' orbitopathyQ38367695
Current Insights into the Pathogenesis of Graves' OphthalmopathyQ38585018
Natural course of mild Graves' orbitopathy: is it a chronic remitting or a transient disease?Q38963406
Statins are not a risk factor for liver damage associated with intravenous glucocorticoid pulse therapy for Graves' orbitopathy.Q39552770
Risk Factors for Graves' Orbitopathy; the Australian Thyroid-Associated Orbitopathy Research (ATOR) Study.Q40812821
Statins may increase the risk of liver dysfunction in patients treated with steroids for active graves' orbitopathy.Q42156382
SERUM HIGH CHOLESTEROL IS A NOVEL RISK FACTOR FOR GRAVES' ORBITOPATHY (GO): RESULTS OF A CROSS-SECTIONAL STUDY.Q48515824
Exophthalmometric values in a normal Turkish population living in the northeastern part of Turkey.Q51747305
Reliability of exophthalmos measurement and the exophthalmometry value distribution in a healthy Dutch population and in Graves' patients. An exploratory study.Q52969900
Action of three bioavailable antioxidants in orbital fibroblasts from patients with Graves' orbitopathy (GO): a new frontier for GO treatment?Q53192241
Radioiodine-Associated Exacerbation of Graves' Orbitopathy in the Japanese Population: Randomized Prospective Study.Q53510651
2016 European Guidelines on cardiovascular disease prevention in clinical practiceQ56068836
Effect of Abnormal Thyroid Function on the Severity of Graves' OphthalmopathyQ67657511
Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathyQ74010201
Effects of total thyroid ablation versus near-total thyroidectomy alone on mild to moderate Graves' orbitopathy treated with intravenous glucocorticoidsQ79771160
Thyroid-associated ophthalmopathy after treatment for Graves' hyperthyroidism with antithyroid drugs or iodine-131Q84506454
Statin reduces orbitopathy risk in patients with Graves' disease by modulating apoptosis and autophagy activitiesQ86387770
Long-term outcome of Graves' orbitopathy following high-dose intravenous glucocorticoids and orbital radiotherapyQ86549348
P433issue12
P304page(s)1417-1423
P577publication date2018-06-19
P1433published inJournal of Endocrinological InvestigationQ15766847
P1476titleRelationship between serum cholesterol and Graves' orbitopathy (GO): a confirmatory study
P478volume41

Reverse relations

cites work (P2860)
Q58767473A Renewed Focus on the Association Between Thyroid Hormones and Lipid Metabolism
Q89620715Cholesterol Serum Levels and Use of Statins in Graves' Orbitopathy: A New Starting Point for the Therapy
Q90496708Therapeutic Effect of Guggulsterone in Primary Cultured Orbital Fibroblasts Obtained From Patients with Graves' Orbitopathy

Search more.